AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

In recognition of World Cancer Day 2025, AstraZeneca reaffirms its commitment to advancing early detection, innovative ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

After recent launches of biosimilar versions of Eylea and Stelara, Amgen projects its biosimilar sales will reach $4 billion ...

Harvey Jones called on artificial intelligence to help him decide where to invest this year's Stocks and Shares ISA allowance ...

Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.

Trump's tariffs could derail Europe's 2025 growth, say top Wall Street analysts. Goldman Sachs sees eurozone GDP at 0.7%, ...

Businesses are “abandoning the North Sea” because of Sir Keir Starmer’s decisions, Kemi Badenoch has claimed at PMQs.

By Ernest Bako WUBONTO The withdrawal of agricultural support programmes threatens to reverse years of progress in food ...

Manchester’s health and life sciences sector is thriving, but as experts at Insider’s roundtable discussed, unlocking its full potential will require greater ...

TD Cowen analyst Steve Scala maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $32.00. The company’s ...